DG Comp opens investigation into Lundbeck
Friday, 8 January 2010
Rachel Bull
The European Commission yesterday launched an inquiry of Danish pharmaceutical company Lundbeck on suspicion of abusing its dominant position in the generic drug market.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to top